NEWBORN SCREENING

Newborn screening is a process of testing all newborn infants for a variety of genetic, metabolic, and other conditions that can cause serious health problems. Newborn screening is typically performed within the first few days of life and can help to identify conditions that might otherwise go unnoticed, allowing for early treatment and intervention.

Newborn screening is performed using a small blood sample, taken from the baby's heel. Newborn screening is a critical component of preventive health care for newborns and can help to identify and treat serious health conditions before they cause significant harm. If a condition is identified through newborn screening, prompt treatment can improve health outcomes and reduce the risk of long-term complications.
Our newborn screening consists of two panels:

Economy Panel

  • Sickle Cell Disease (SS, SC)
  • HbE
  • Beta-Thalassemia
  • Congenital Hypothyroidism
  • Glucose-6-Phosphate Dehydrogenase
  • Congenital Adrenal Hyperplasia

Standard Panel

  • Sickle Cell Disease (SS, SC)
  • HbE
  • Beta-Thalassemia
  • Galactosemia
  • Congenital Hypothyroidism
  • Glucose-6-Phosphate Dehydrogenase
  • Congenital Adrenal Hyperplasia
  • Phenylketonuria
  • Biotinidase Deficiency
  • Cystic Fibrosis